Skip to main content
LTRN
NASDAQ Life Sciences

Lantern Pharma Plans AI Platform Spin-Off, Reports Reduced Q1 Loss and Clinical Milestones

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.14
Mkt Cap
$35.497M
52W Low
$1.11
52W High
$5.744
52W Position info
183% above low
Off High info
45% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LTRN has more than doubled off its 52-week low of $1.11.

Summary

Lantern Pharma reported strong first-quarter 2026 financial results, including a 27% reduction in net loss and a 47% decrease in R&D spend year-over-year. The company also announced the commercial launch of its multi-agentic AI platform, withZeta.ai, and a significant strategic plan to create an independent entity for these AI assets. This move aims to unlock dedicated funding and allow for separate valuation of the AI business, potentially creating substantial shareholder value. Additionally, Lantern Pharma achieved a successful FDA Type C meeting outcome for its LP-300 HARMONIC trial and received IND clearance for a pediatric brain cancer program. While the $4.4 million financing mentioned was previously announced in recent SEC filings and news, the overall financial improvements, clinical progress, and especially the strategic spin-off plan are new and highly material. Investors will be closely watching for further details on the AI platform spin-off and continued progress in its clinical pipeline.

At the time of this announcement, LTRN was trading at $3.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $35.5M. The 52-week trading range was $1.11 to $5.74. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LTRN - Latest Insights

LTRN
Nov 18, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.3724
Real-time Price: $0.280 info
Change: -$0.0924 (-25%) info
Market Cap: $4.51M info
LTRN
Nov 18, 2026, 7:35 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3724
Real-time Price: $0.280 info
Change: -$0.0924 (-25%) info
Market Cap: $4.51M info
LTRN
Nov 17, 2026, 4:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.365
Real-time Price: $0.280 info
Change: -$0.085 (-23%) info
Market Cap: $4.51M info
LTRN
Oct 08, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.830
Real-time Price: $0.280 info
Change: -$0.550 (-66%) info
Market Cap: $4.51M info
LTRN
Oct 07, 2026, 8:31 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.280 info
Change: -$0.670 (-71%) info
Market Cap: $4.51M info